Abstract:Background: To study the expression of the RIZ1 (Retinoblastoma protein-interacting zinc-finger gene 1) gene and investigate the promoter region methylation status of RIZ1 gene in the human esophageal squamous cell carcinoma (ESCC) cell lines of KYSE150, KYSE510, TE13, EC9706, CaEs17, and EC109. To investigate the influence of DNMT (DNA methyltransferase) 5-aza-CdR(5-aza-2'-deoxycytidine) on the transcription of the RIZ1 gene in one cell line whose RIZ1 gene promoter region methylation was detected, and to investigate its influence on the cell proliferation.Methods: Real-time PCR (Real-time quantitative PCR) and an immunohistochemistry technique was used to get the expression of RIZ1 in specimens from 6 human ESCC cell lines and 28 ESCC patients (tumor tissues and adjacent non-cancerous tissues). MSP (Methylation-specific PCR) was used to investigate the promoter region methylation status of the RIZ1 gene in the 6 ESCC cell lines. One cell line, whose RIZ1 gene promoter region methy-lation was detected, was chosen for the next studies in which it was treated it by with 5-aza-CdR. Real-time PCR was used to investigate its influence on the transcription of RIZ1 gene and MTT (methyl thiazolyl tetrazolium) was used to detect if 5-aza-CdR inhibits the proliferation of the cell line.Results: In the 28 ESCC patient samples, RIZ1 expression was significantly lower in the tumor tissues than that in their adjacent non-cancerous tissues (p<0.05). Consistently, immunohistochemistry analyses of RIZ1 protein expression showed that in the ESCC tissues RIZ1 protein expression was also significantly lower than in the adjacent tissues. In the human ESCC tissues the rate of expression accounts for 0% (0/12), and in the adjacent non-cancerous tissues the rate of expression was 66.7% (8/12), the correlation was highly significant (chi(2) = 12.000, p<0.05). Promoter methylation of the RIZ1 gene was detected in TE13, CaEs17, EC109. The cell line TE13 was chosen for the next studies. The expression of RIZ1 mRNA in TE-13 was up-regulated after having been treated with 5-aza-CdR. 5-aza-CdR inhibited cell proliferation of TE-13 in a time and concentration-dependent manner.Conclusions: Promoter methylation may play an important role in the epigenetic silencing of RIZ1 gene expression. Methylation of the RIZ1 promoter and loss of RIZ1 expression in human ESCC are independent biomarkers. Their determination may offer guidance for selecting appropriate diagnoses and treatments. RIZ1 may be a potential tumor suppressor in human ESCC. (Clin. Lab. 2012;58:41-51)

Expression and DNA Methylation Status of Long Non-coding RNA ZNF667-AS1 in Esophageal Squamous Cell Carcinoma Tissues

Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma

Dna Methylation Status Of Pax1 And Znf582 In Esophageal Squamous Cell Carcinoma

Expression and methylation status of CAV-1 gene in esophageal squamous cell carcinoma

Expression and methylation status of different transcripts of RASSF5 in esophageal squamous cell carcinoma

Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma

Promoter Methylation and Protein Expression of Apoptosis Protease Activating Factor-1 Gene in Esophageal Squamous Cell Carcinoma

High methylation of the same promoter of lncRNA ZNF582-AS1/ ZNF582 promotes malignant progression of esophageal cancer

Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma

Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.

The expression and methylation status of miR-203b gene in esophageal squamous cell carcinoma

Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells

Decreased Expression of Retinoblastoma Protein-Interacting Zinc-Finger Gene 1 in Human Esophageal Squamous Cell Cancer by DNA Methylation.

Hypermethylation Status of RASSF1A Gene Promoter Region in Esophageal Squamous Cell Carcinoma

Effect of aberrant methylation of DACT1 gene different regions on prognosis of the patients with esophageal squamous cell cancer

Expression and Methylation Status of DACT2 Gene in Esophageal Squamous Cell Carcinoma

Methylation status of CpG island of Smad4 gene in esophageal squamous cell carcinoma

Aberrant Hypermethylation of RASSF2 in Tumors and Peripheral Blood DNA As a Biomarker for Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma.

Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation

Promoter Methylation-Associated Silencing Of P27kip1 Gene With Metastasis In Esophageal Squamous Cell Carcinoma

Hypermethylation and Aberrant Expression of SRY-box 17 Gene in Esophageal Squamous Cell Cancer